Speaking of SurgOnc

Speaking of SurgOnc

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

Episodes

July 13, 2021 11 min

Rick Greene, MD and Nancy Cho, MD discuss the impact of the 2015 American Thyroid Association guideline change on clinical practice in low-risk differentiated thyroid cancer, specifically regarding the rate of completion thyroidectomy. Dr. Cho is author of the article, “Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines.”

Dr. Cho is Associate Surgeon, Brigham and Women's Hospi...

Share
Mark as Played

Rick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatment with parathyroidectomy. Dr. Balentine is author of, "Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons."

Dr. Balentine is Assistant Professor of General and Endocrine Surgery, and Co-Director of the ...

Share
Mark as Played

Rick Greene, MD and Vivian Strong, MD discuss factors associated with quality-of-life recovery after gastrectomy. Dr. Strong is author of “Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer.”

Dr. Strong is the Iris Cantor Endowed Chair and Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery and Associate Dean, Weill Cornell Medical College of Cornell University; and Vice Chair...

Share
Mark as Played

Rick Greene, MD, and Melissa Hogg, MD, discuss the relationship of serum CA19-9 to other markers of response, and the related thresholds correlating to outcomes, following neoadjuvant therapy for pancreatic adenocarcinoma. Dr. Hogg is author of the article, “Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma.”

Dr. Hogg is the Director of HPB Surgery and Director of R...

Share
Mark as Played

Rick Greene, MD, and Ken Tanabe, MD, discuss the need for surgical oncologists to remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic continues to impose. Dr. Tanabe is author of, "Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change."

Dr. Tanabe is a Professor of Surgery at Harvard Medical School ...

Share
Mark as Played

Rick Greene, MD and Charlotte Ariyan, MD, PhD, discuss survival outcomes in patients with metastatic melanoma who were selected for surgery following checkpoint blockade. Dr. Ariyan is author of, “Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.”

Dr. Ariyan is Associate Professor of Surgery, Weill Cornell Medical College, and a Surgeon with clinical expertise in melanoma an...

Share
Mark as Played

Rick Greene, MD and Katie Egan, MD discuss the use of an educational intervention to decrease opioid consumption among breast surgery patients. Dr. Egan is author of the article, “Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial.”

Dr. Egan is Plastic and Reconstructive Surgery Resident at The University of Kansas Medical Center in Kansas City, KS.

Share
Mark as Played

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.”

Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.

Share
Mark as Played

Rick Greene, MD, and Alexandra Gangi, MD and James Howe, MD, discuss current data regarding management of neuroendocrine liver metastases and future areas for study. Dr. Gangi and Dr. Howe are authors of “The Landmark Series: Neuroendocrine Tumor Liver Metastases.”

Dr. Gangi is Assistant Professor of Surgery in the Department of Surgical Oncology and the Director of the Gastrointestinal Tumor Program at Cedars-Sinai, Los Angeles, C...

Share
Mark as Played

Rick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, “Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.”

Dr. Karakousis is Associate Professor of Surgery at the Hospital of t...

Share
Mark as Played

Rick Greene, MD, and Michael D’Angelica, MD discuss the relationship between hepatic parenchymal disease and recurrence after colorectal liver metastases resection, which has not been well defined. Dr. D’Angelica is author of, “Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.”

Dr. D’Angelica holds the Enid A. Haupt Chair in Surgery at Memorial Sloan Kettering Cancer ...

Share
Mark as Played

Rick Greene, MD and Elizabeth Grubbs, MD, MS discuss an analysis of the applicant pool of complex general surgical oncology (CGSO) fellowships and how it has changed over the last decade.

Dr. Grubbs is author of, “Complex General Surgical Oncology Fellowship Applicants: Trends over Time and the Impact of Board Certification Eligibility.”

Dr. Grubbs is Associate Professor, Program Director of Complex General Surgical Oncology Fellow...

Share
Mark as Played

Rick Greene, MD and Julie Hallet, MD discuss the moderate-to-severe symptoms observed to steeply increase as death nears for patients with neuroendocrine tumors (NETs), which highlight an opportunity for improved management.

Dr. Hallet is author of, “Symptom Burden at the End of Life for Neuroendocrine Tumors: An Analysis of 2579 Prospectively Collected Patient-Reported Outcomes.”

Dr. Hallet is Assistant Professor, Surgical Oncolog...

Share
Mark as Played

Dr. Greene and Dr. Plichta discuss the potential benefit for women from genetic testing for BRCA1, BRCA2, and other breast cancer genes and the knowledge needed by breast surgeons to facilitate testing and counseling.

Dr. Plichta is author of, “Germline Genetic Testing: What the Breast Surgeon Needs to Know.”

Dr. Plichta is an Assistant Professor of Surgery, Division of Surgical Oncology, Duke Surgery, Duke University School of Me...

Share
Mark as Played

Rick Greene, MD and Marissa M. Howard-McNatt, MD discuss how the requirements for maintenance of certification (MOC) and CME changed in 2018, and review the options for completing these requisites.

Mariss M. Howard-McNatt, MD is author of, “Maintenance of Certification and Continuing Medical Education: Are They Still Required?”

Marissa M. Howard-McNatt, MD is an Associate Professor of Surgery Sciences – Oncology, Wake Forest School...

Share
Mark as Played

Dr. Greene and Dr. Jeruss discuss the potential impact of treatment on the future fertility of young breast cancer patients and review guidelines provided to address reproductive health in conjunction with a breast cancer diagnosis.

Dr. Jeruss is author of, “Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.”

Dr. Jeruss is an Associate Professor of Surgery at Departm...

Share
Mark as Played

Dr. Rick Greene and Dr. Andrew J. Rosko discuss how intraoperative usage of indocyanine green imaging can predict the formation of post-operative fistulas, allowing for more tailored reconstructive options depending on risk of fistula.

Dr. Rosko is author of, “Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.”

Dr. Rosko is a Clinical Assistant Professor, Department of Otolaryngolo...

Share
Mark as Played

Dr. Rick Greene and Dr. Paxton Dickson discuss adrenocortical carcinoma and related issues regarding adjuvant and neoadjuvant therapy, treatment of advanced disease, and genetic considerations for patients who have this disease.

Dr. Dickson is author of, “Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disea...

Share
Mark as Played

Dr. Rick Greene and Dr. Clancy Clark discuss the use of a modified frailty index as a predictor in pancreaticoduodenectomy, its association with postoperative morbidity and mortality, and how it can aid in preoperative risk stratification.

Dr. Clark is author of, “Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy.”

Dr. Clark is an Assistant Professor, Department of Surgery, at Wake Forest Baptist...

Share
Mark as Played

Dr. Rick Greene and Dr. Basem Azab discuss the relationship of the interval between neoadjuvant chemoradiation-to-surgery in the treatment of esophageal cancer, and associated pathological complete response rate and overall survival rate.

Dr. Azab is author of the Annals of Surgical Oncology article “Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophagea...

Share
Mark as Played

Popular Podcasts

  • If you can never get enough true crime... Congratulations, you’ve found your people.

  • Dr. Death

    We’re at our most vulnerable when we go to our doctors. We trust the person at the other end of that scalpel. We trust the hospital. We trust the system. Christopher Duntsch was a neurosurgeon who radiated confidence. He claimed he was the best in Dallas. If you had back pain, and had tried everything else, Dr. Duntsch could give you the spine surgery that would take your pain away. But soon his patients started to experience complications, and the system failed to protect them. Which begs the question: who - or what - is that system meant to protect? From Wondery, the network behind the hit podcast Dirty John, DR. DEATH is a story about a charming surgeon, 33 patients and a spineless system. Reported and hosted by Laura Beil.

  • The Daily

    This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro. Twenty minutes a day, five days a week, ready by 6 a.m.

  • Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

  • Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.

Facebook comments will no longer be available on iHeart

We're taking steps to simplify your experience. If you want to reach out to our hosts or stations, please do so via their website or social media. If you need any assistance please check out our help site.

Chat About Speaking of SurgOnc

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeartRadio App.

Connect

© 2021 iHeartMedia, Inc.